Elinx : Annual Report - Year End (6/30/2021)

ELINX CORPORATION

(FORMERLY KNOWN AS APERTURE HEALTH, INC.)

BALANCE SHEETS

June 30,		June 30,
2021		2020

ASSETS

CURRENT ASSETS

Cash

Accounts receivable

Total Current Assets

Property and equipment, net of accumulated depreciation

TOTAL ASSETS

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES

Accounts payable and accrued liabilities

Notes payable - related parties

Total Current Liabilities

LONG TERM LIABILITIES

Notes payable

TOTAL LIABILITIES

STOCKHOLDERS' EQUITY

Common stock; $0.001 par value, 480,000,000 shares authorized; 24,908,956 and 24,908,956 shares issued and outstanding at June 30, 2021 and June 30, 2020, respectively

Additional Paid-in Capital

Accumulated Deficit

Total Stockholders' Equity

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

	$		374,557					$		8,859
		144,596						-
			519,153							8,859
			177.976							223,418
	$	697,129	$	232,277

	$		244,634						$		155,025
			39,486								-
		284,120							155,025
	$		114,792						$		-
		398,912	$	-

24,909

24,909

2,262.697 2,262,697

(1,989,389) (2,210,354 )

298,21777,252

$

697,129

$

232,277

See accompanying notes to financial statements

ELINX CORPORATION

(FORMERLY KNOWN AS APERTURE HEALTH, INC.)

STATEMENTS OF OPERATIONS

					For the Year Ended
					June 30,								June 30,
			2021							2020
REVENUES
Processing revenue			$		1,241,077						$		-
TOTAL REVENUES	1,241,077
COST OF SERVICES	606,172							-
GROSS PROFIT					634,905								-
OPERATING EXPENSES
Depreciation	45,441							3,787
General and administrative					974,671								2,110,541
Total Operating Expenses	1,020,112							2,114,378
OPERATING INCOME (LOSS)					220,965								(2,114,328		)
Other Income (Expense)
					-								-
			-							-
Total Other Income (Expense)													-

NET INCOME (LOSS) BEFORE INCOME TAXES

Provision for Income Taxes

NET INCOME (LOSS)

BASIC AND DILUTED EARNINGS (LOSS) PER SHARE

BASIC AND DILUTED WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING

See accompanying notes to financial statements

	220,965
	-
$	220,965

$	0.01
	24,908,956

(2,114,328 )

-

$(2,114,328 )

$(0.12 )

17,746,148

ELINX CORPORATION

(FORMERLY KNOWN AS APERTURE HEALTH, INC.)

STATEMENT OF STOCKHOLDERS' EQUITY

														Additional												Total
				Common Stock						Paid-In				Accumulated		Stockholders'
				Shares				Amount						Capital						Deficit					Equity
Balance, June 30, 2019	1,066,956	$ 1,067	$ 94,959	$	(96,026)			$	-
Common stock issued for cash				50,000						50						24,950						-						25,000
Common stock issued for compensation	21,267,500	21,268	1,918,108					-					1,939,376
Common stock issued for assets				2,524,500						2,525						224,680						-						227,205
Net loss for the year	-	-	-					(2,114,328)				(2,114,328)

Balance, June 30, 2020

Net income for the year

Balance, June 30, 2021

24,908,956	$	24,909
-		-
24,908,956	$	24,909

$ 2,262,697 $

-

$ 2,262,697 $

(2,210,354		)			$		77,252
220,965						220,965
(1,989,389		)			$		298,217

See accompanying notes to financial statements

ELINX CORPORATION

(FORMERLY KNOWN AS APERTURE HEALTH, INC.)

STATEMENTS OF CASH FLOWS

					For the Years Ended
					June 30,				June 30,
			2021				2020
OPERATING ACTIVITIES
Net income (loss)			$		220,965					$		(2,114,328		)
Adjustments to reconcile net income (loss) to net cash provided by operating
activities:
Depreciation					45,442							3,787
Shares issued for stock-based compensation	-				1,939,375
Changes in operating assets and liabilities
Account receivable	(144,596 )
Accounts payable and accrued liabilities					89,605							155,025
Net Cash Provided by (Used in) Operating Activities	211,420				(16,141 )
INVESTING ACTIVITIES
Purchase of property and equipment					-							-
Net Cash Used in Financing Activities	-				-
FINANCING ACTIVITIES
Proceeds from issuance of stock for cash												25,000
Proceeds from notes payable - related party	39,486
Proceeds from notes payable					114,792
Net Cash Provided by Financing Activities	154,278				-
NET INCREASE IN CASH					365,698
CASH AT BEGINNING OF PERIOD	8,859				-

CASH AT END OF PERIOD

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: CASH PAID FOR:

Interest

Income taxes

$

374,557

$	-
$	-

	$		-

	$		-
	$		-

NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common shares issued for assets	$	- $	227,205

See accompanying notes to financial statements

ELINX CORPORATION

(FORMERLY KNOWN AS APERTURE HEALTH, INC.)

NOTES TO THE FINANCIAL STATEMENTS For the Years Ended June 30, 2021 and 2020

Note 1 - Organization and Operations

The Company, formerly known as Fuel Corporation, and then as Aperture Health, Inc.. (the "Company," which is now known as Elinx Corporation), was incorporated on September 8, 2005 under the laws of the State of Nevada. On January 19, 2019, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada effecting a name change from Aperture Health, Inc. to Elinx Corporation. On December 18, 2019, the Company entered into an agreement to acquired assets from Crown Financial to participate in the sand fracking business. These assets were entered into from an issuance of the Company's common stock This transaction did not finalize until May of 2020.

Note 2 - Significant and Critical Accounting Policies and Practices

The Management of the Company is responsible for the selection and use of appropriate accounting policies and the appropriateness of accounting policies and their application. Critical accounting policies and practices are those that are both most important to the portrayal of the Company's financial condition and results and require management's most difficult, subjective, or complex judgments, often as a result of the need to make estimates about the effects of matters that are inherently uncertain. The Company's significant and critical accounting policies and practices are disclosed below as required by generally accepted accounting principles.

Basis of Presentation

The accompanying financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP"), and with the rules and regulations of the United States Securities and Exchange Commission ("SEC"). The Company has elected June 30th as its fiscal year ending date.

Use of Estimates and Assumptions and Critical Accounting Estimates and Assumptions

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date(s) of the financial statements and the reported amounts of revenues and expenses during the reporting period(s).

These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.

Actual results could differ from those estimates.

Fair Value of Financial Instruments

The Company follows ASC 820, "Fair Value Measurement," to measure and disclose the fair value of its financial instruments. ASC 820 establishes a framework for measuring fair value in accordance with GAAP, and expands